Heart Failure Society of America

The latest news from the HFSA Annual Scientific Meeting, with physician perspective, researcher interviews and clinician insight.

Meeting News

Debate: LVEF significance or lack thereof in HF decision-making

October 1, 2019
PHILADELPHIA — The consideration of left ventricular ejection fraction when diagnosing or making treatment decisions for HF was a topic for…
Meeting NewsPerspective

Sacubitril/valsartan beneficial in real-world HFrEF population

September 23, 2019
PHILADELPHIA — In a real-world population of patients hospitalized for HF with reduced ejection fraction, sacubitril/valsartan was associated…
Meeting News

Transcatheter mitral valve repair system safe, effective at 6 months

September 20, 2019
PHILADELPHIA — Six-month data from the CLASP study showed a transcatheter mitral valve repair system for patients with functional mitral…
Meeting News

Q&A: Shaq 'gets real' about HF awareness in black population

September 17, 2019
PHILADELPHIA — Shaquille O’Neal, PhD, FHSFA, retired basketball star and winner of four NBA championships, discussed the recently…
Meeting News

TRI-REPAIR: Valve reconstruction system reduces tricuspid regurgitation at 1 year

September 17, 2019
PHILADELPHIA — The success of a transcatheter tricuspid valve reconstruction system in patients with tricuspid regurgitation was maintained at…
Meeting News

LV end-diastolic pressure significant marker for outcomes after heart catheterization

September 17, 2019
PHILADELPHIA — Following left heart catheterization, offloading measured by left ventricular end-diastolic pressure was a notable marker for…
Meeting News

Virtual visits feasible for patients transitioning to home after HF: ViV-HF

September 16, 2019
PHILADELPHIA — The Virtual Visits and Heart Failure Care Transition, or ViV-HF, trial proved the feasibility of substituting inpatient visits…
Meeting News

AMBER: Patiromer enables persistent spironolactone treatment in patients with hypertension, CKD

September 16, 2019
PHILADELPHIA — Concomitant use of the potassium binder patiromer enabled more patients with resistant hypertension and advanced chronic kidney…
Meeting NewsPerspective

PARAGON HF Echo: RV enlargement among predictors of events in HFpEF

September 16, 2019
PHILADELPHIA — Right ventricular enlargement, left ventricular hypertrophy and elevated left- and right-sided pressures were among the…
Meeting NewsPerspective

DEFINE-HF: Dapagliflozin improves HF-related health regardless of diabetes status

September 16, 2019
PHILADELPHIA — In patients with HF with reduced ejection fraction with or without diabetes, the SGLT2 inhibitor dapagliflozin was associated…

Meeting Calendar

Heart Failure Society of America Annual Scientific Meeting

October 2, 2020 - October 5, 2020